Evidence map›Paper›PMID 27011791›Full record

ReviewJournal of intensive care2016

Sepsis-induced myocardial dysfunction: pathophysiology and management.

Yasuyuki Kakihana, Takashi Ito, Mayumi Nakahara, Keiji Yamaguchi, Tomotsugu Yasuda

3 registry-linked trialsOpen access · goldAbstract readReview
In one paragraph

Review in Journal of intensive care, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 3 registered trials, which are not on this map. Cited by 284 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
284citing papers in PubMed, 1 pooled it
23.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05202938 unknown statusnot on this mapstarted 2022, after this paper: background citation

Energy MEtabolism of Septic Heart.

TypeobservationalSponsorCentre de recherche du Centre hospitalier universitaire de SherbrookeRan2022 to 2024Enrolled32ConditionsSeptic Shock, Chronic Heart FailureArmsultrasound cardiography, FDG PET scan, Palmitate PET scan, Acetate PET scan, Blood sampling
NCT05793008 narecruitingnot on this mapstarted 2023, after this paper: background citation

Characterization of priMary And sEcondary STress Related takOtsubo: the MAESTRO Pilot Study

TypeinterventionalSponsorFondazione Policlinico Universitario Agostino Gemelli IRCCSRan2023 to 2026Enrolled60ConditionsTakotsubo Cardiomyopathy, Sepsis-induced CardiomyopathyArmsPositron Emission Tomography (PET) analysis, Blood samples collection, Clinical follow up visit
NCT07442032 not yet recruitingnot on this mapstarted 2026, after this paper: background citation

Cardiovascular Phenotypes in Sepsis

TypeobservationalSponsorKarolinska InstitutetRan2026 to 2029Enrolled400ConditionsSepsis, Septic Shock, Cardiovascular Dysfunction, Microcirculatory Dysfunction
3 · Its place in the literature

Who cites it

284 citing papers in PubMed, 1 synthesis or guideline pooled it, 514 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. ToxCompl completion of the DrugMatrix toxicogenomics database: an integrated resource for hypothesis generation.Toxicological sciences : an official journal of the Society of Toxicology · 2026
    Article
  5. Article
  6. BGP-15 ameliorates sepsis-induced cardiomyopathy via SIRT3/SOD2-associated antioxidant signaling and suppression of myocardial inflammation.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2026
    Article
  7. Article
  8. Article
  9. Observational
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Association Between Myocardial Dysfunction and Septic Shock.International journal of molecular sciences · 2026
    Review
  17. Knockdown of SOX4 attenuates sepsis myocardial injury by inhibiting the EZH2/H3K27me3/SOCS3 axis.Mammalian genome : official journal of the International Mammalian Genome Society · 2026
    Article
  18. Observational
  19. Review
  20. Article

224 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Yasuyuki KakihanaDepartment of Emergency and Intensive Care Medicine, Kagoshima University Graduate School of Medical and Dental Sciences, 8-35-1 Sakuragaoka, Kagoshima, 890-8520 Japan.
Takashi ItoDepartment of Emergency and Intensive Care Medicine, Kagoshima University Graduate School of Medical and Dental Sciences, 8-35-1 Sakuragaoka, Kagoshima, 890-8520 Japan ; Department of Systems Biology in Thromboregulation, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan.
Mayumi NakaharaDepartment of Anesthesiology and Critical Care Medicine, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan.
Keiji YamaguchiDepartment of Emergency and Intensive Care Medicine, Kagoshima University Graduate School of Medical and Dental Sciences, 8-35-1 Sakuragaoka, Kagoshima, 890-8520 Japan.
Tomotsugu YasudaDepartment of Emergency and Intensive Care Medicine, Kagoshima University Graduate School of Medical and Dental Sciences, 8-35-1 Sakuragaoka, Kagoshima, 890-8520 Japan.
Kagoshima University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Sepsis is aggravated by an inappropriate immune response to invading microorganisms, which occasionally leads to multiple organ failure. Several lines of evidence suggest that the ventricular myocardium is depressed during sepsis with features of diastolic dysfunction. Potential candidates responsible for septic cardiomyopathy include pathogen-associated molecular patterns (PAMPs), cytokines, and nitric oxide. Extracellular histones and high-mobility group box 1 that function as endogenous damage-associated molecular patterns (DAMPs) also contribute to the myocardial dysfunction associated with sepsis. If untreated, persistent shock causes cellular injury and the liberation of further DAMPs. Like PAMPs, DAMPs have the potential to activate inflammation, creating a vicious circle. Early infection control with adequate antibiotic care is important during septic shock to decrease PAMPs arising from invasive microorganisms. Early aggressive fluid resuscitation as well as the administration of vasopressors and inotropes is also important to reduce DAMPs generated by damaged cells although excessive volume loading, and prolonged administration of catecholamines might be harmful. This review delineates some features of septic myocardial dysfunction, assesses its most common underlying mechanisms, and briefly outlines current therapeutic strategies and potential future approaches.

Indexed as

Damage-associated molecular patternsImmune systemInfectionSeptic shockSystemic inflammatory response syndrome

Identifiers

PMID27011791
PMCPMC4804632
OpenAlexW2303241606

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.